Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress

Huizinga T, Holers M, Anolik J, Brenner M, Buckley CD, Bykerk V, Connolly S, Deane K, Guo J, Hodge M, Hoffmann S, Nestle F, Pitzalis C, Raychaudhuri S, Yamamoto K, Li Z, Klareskog L. Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress. Annals of the Rheumatic Diseases. 2020;79(5):553–555.
Last updated on 03/06/2023